Hypertension in diabetes. secondary hypertension
Conditions
Interventions
Intervention 1: Intervention group: chewable vitamin C supplement at a dose of 250 mg 4 times a day during 6 weeks. Intervention 2: Control group: chewable placebo of vitamin C 4 times a day for 6 wee
Treatment - Drugs
Placebo
Intervention group: chewable vitamin C supplement at a dose of 250 mg 4 times a day during 6 weeks
Control group: chewable placebo of vitamin C 4 times a day for 6 weeks
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with diabetes and hypertension; overweight; more than 30 years of age and under 60 years of age; not smoking and alcohol; non kidney stones; non use of oral contraceptives pills in women; fasting blood sugar of 126 to 250. Exclusion criteria: changes in medications; non-use of prescribed supplements; Unwillingness to engage in continuing study; the use of a specific treatment regimen
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: on the first intervention and on the forty-second day. Method of measurement: Mercury Sphygmomanometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting blood sugar. Timepoint: At the beginning and the end of study. Method of measurement: Method of Glucose Oxidase. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Seyed Ali Keshavarz
Tehran University of Medical Sciences
Outcome results
None listed